SEI Investments
AUPH icon

SEI Investments’s Aurinia Pharmaceuticals AUPH Stock Holding History

SEI Investments’s Portfolio AUPH Stock Details AUPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$739K Buy
45,624
+22,268
+95% +$355K ﹤0.01% 2454
2026
Q2 		$396K Buy
23,356
+2,711
+13% +$43.3K ﹤0.01% 2740
2026
Q1 		$306K Buy
20,645
+137
+0.7% +$2K ﹤0.01% 2822
2025
Q4 		$327K Sell
20,508
-22,919
-53% -$325K ﹤0.01% 2692
2025
Q3 		$480K Buy
+43,427
New +$474K ﹤0.01% 2248

Other funds holding AUPH

State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $54.1B AUM 39.29% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $73.4B AUM 32.8% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
Jupiter Asset Management
Jupiter Asset Management London, United Kingdom $21.4B AUM 19.74% 1-Year Est. Return
O'Shaughnessy Asset Management
O'Shaughnessy Asset Management Stamford, Connecticut $23.6B AUM 34.05% 1-Year Est. Return
Hillsdale Investment Management
Hillsdale Investment Management Toronto, Ontario, Canada $4.42B AUM 54.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $71.4B AUM 33.43% 1-Year Est. Return

SEI Investments's AUPH Position: Q3 2026 in Review

SEI Investments increased its Aurinia Pharmaceuticals (AUPH) stake by 95% in Q3 2026, buying an estimated $355K and bringing the position to 45,624 shares worth $739K. The position accounts for ﹤0.01% of the portfolio, ranked #2454.

SEI Investments first reported a position in AUPH in Q3 2025 and has held it in 5 quarters since. 169 funds tracked by Wall St. Rank hold AUPH as of Q3 2026.

  • SEI Investments held 45,624 shares of Aurinia Pharmaceuticals worth $739K as of Q3 2026.
  • SEI Investments bought 22,268 Aurinia Pharmaceuticals shares in Q3 2026, an estimated $355K.
  • Aurinia Pharmaceuticals made up ﹤0.01% of SEI Investments's portfolio in Q3 2026, its #2454 holding.
  • SEI Investments first reported a position in Aurinia Pharmaceuticals in Q3 2025 and has held it in 5 quarters since.
  • 169 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q3 2026.

Based on SEI Investments's 13F filing for Q3 2026, filed 10 Nov 2026.